EcoDrugPlus

Adrenoceptor Alpha 2a

Ensembl ID : ENSSDUG00000015352
Gene Symbol: ADRA2A
3 Cross references
159 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSSDUG00000010185
Gene Symbol: ADRA2A
1 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSSDUG00000006330
Gene Symbol: ADRA2B
1 Cross references
149 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSSDUG00000003296
Gene Symbol: ADRA2B
1 Cross references
174 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSSDUG00000020063
Gene Symbol: ADRA2C
4 Cross references
157 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSSDUG00000001616
Gene Symbol: ADRA2C
1 Cross references
160 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSSDUG00000021984
Gene Symbol: ADRB1
1 Cross references
161 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSSDUG00000020160
Gene Symbol: ADRB2
3 Cross references
192 Possible Orthologues:

Adrenoceptor Beta 2, Surface A

Ensembl ID : ENSSDUG00000010174
Gene Symbol: ADRB2A
1 Cross references
195 Possible Orthologues:

Adrenoceptor Beta 3a

Ensembl ID : ENSSDUG00000020306
Gene Symbol: ADRB3A
1 Cross references
196 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSSDUG00000007526
Gene Symbol: LOC111224606
3 Cross references
343 Possible Orthologues:

Aldose Reductase-Like

Ensembl ID : ENSSDUG00000007485
Gene Symbol: LOC111224660
3 Cross references
345 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).